BrightSpring Health Services – Specialty Medications and Home Care Drive Growth
Reading Time: 3 minutes
The US specialty pharmacy market is expected to grow by 11% annually. Over 415 therapies are in phase-3 studies. BrightSpring manages 162 specialty medications with restricted distribution. New contracts create growth potential. The number of individuals over 85 years old in the US is projected to double by 2040. BrightSpring raises its earnings forecast. When screening for growth stocks with relative strength, BrightSpring Health Services (BTSG) stands out. The company offers specialty medications, infusions, and home care. New drugs...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
